Share the post "Kwality Pharmaceuticals announced Financial Results Q1 2024-25"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 18.72 % in the past year, decrease in net sales/revenue by -12.94 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -29.8 %, Marginal increase in other income during this quarter, up by 104.27%.
- Profit over the Year and quarter: Significant improvement in profitability for Kwality Pharmaceuticals Limited. Notable increase of 54.5 % in net profit Year to Year, Kwality Pharmaceuticals Limited’s profitability increased by 96.93 % in this quarter.
- EPS over the Year and quarter: EPS increased by 57.65 % Year to Year. EPS increased by 97.06 % in previous quarter. Positive impact on shareholders.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 67.45 Cr | Rs. 91.977 Cr | Rs. 80.079 Cr | -12.94 % | + 18.72 % |
Expenses | Rs. 53.67 Cr | Rs. 71.35 Cr | Rs. 62.73 Cr | -12.08 % | + 16.88 % |
Operating Profit | Rs. 13.78 Cr | Rs. 20.63 Cr | Rs. 17.35 Cr | -15.9 % | + 25.91 % |
OPM % | 20.43 % | 22.43 % | 21.67 % | -0.76 % | + 1.24 % |
Other Income | Rs. 0.396 Cr | Rs. -6.516 Cr | Rs. 0.278 Cr | + 104.27 % | -29.8 % |
Interest | Rs. 2.19 Cr | Rs. 3.06 Cr | Rs. 2.48 Cr | -18.95 % | + 13.24 % |
Depreciation | Rs. 4.79 Cr | Rs. 5.07 Cr | Rs. 4.03 Cr | -20.51 % | -15.87 % |
Profit before tax | Rs. 7.2 Cr | Rs. 5.98 Cr | Rs. 11.12 Cr | + 85.95 % | + 54.44 % |
Tax % | 24.92 % | 29.19 % | 24.93 % | -4.26 % | + 0.01 % |
Net Profit | Rs. 5.4 Cr | Rs. 4.24 Cr | Rs. 8.35 Cr | + 96.93 % | + 54.63 % |
EPS in Rs | Rs. 5.1 | Rs. 4.08 | Rs. 8.04 | + 97.06 % | + 57.65 % |
Today, we’re looking at Kwality Pharmaceuticals Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 18.72 %. However, it did see a marginal slip of -12.94 % from the previous quarter. Expenses decreased slightly by -12.08 % quarter-on-quarter, aligning with the annual rise of 16.88 %. Operating profit, while up 25.91 % compared to last year, faced a quarter-on-quarter dip of -15.9 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 1.24 %, but a shrinkage of -0.76 % sequentially. Other income rose by 104.27 % compared to the last quarter, despite an annual decline of -29.8 %. Interest expenses dropped significantly by -18.95 % from the previous quarter, yet the year-over-year increase remains at a moderate 13.24 %. Depreciation costs fell by -20.51 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -15.87 %. Profit before tax grew annually by 54.44 % but saw an increase from the preceding quarter by 85.95 %.
Tax expenses as a percentage of profits increased slightly by 0.01 % compared to last year, with a more notable quarter-on-quarter decrease of -4.26 %. Net profit rose by 54.63 % year-on-year but experienced a 96.93 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 57.65 % but a quarterly rise of 97.06 %. In summary, Kwality Pharmaceuticals Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 67.45 Cr | Rs. 91.977 Cr | Rs. 80.079 Cr | -12.94 % | + 18.72 % |
Expenses | Rs. 53.67 Cr | Rs. 71.35 Cr | Rs. 62.73 Cr | -12.08 % | + 16.88 % |
Operating Profit | Rs. 13.78 Cr | Rs. 20.63 Cr | Rs. 17.35 Cr | -15.9 % | + 25.91 % |
Net Profit | Rs. 5.4 Cr | Rs. 4.24 Cr | Rs. 8.35 Cr | + 96.93 % | + 54.63 % |
EPS in Rs | Rs. 5.1 | Rs. 4.08 | Rs. 8.04 | + 97.06 % | + 57.65 % |
In reviewing Kwality Pharmaceuticals Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 18.72 % year-on-year growth, although there was a slight dip of -12.94 % from the previous quarter. Expenses rose by 16.88 % compared to the previous year, with a decrease of -12.08 % quarter-on-quarter. Operating Profit surged by 25.91 % annually, and saw a -15.9 % decrease from the last quarter.
Net Profit showed yearly increase of 54.63 %, and experienced a 96.93 % increase from the previous quarter. Earnings Per Share (EPS) rose by 57.65 % annually, however rose by 97.06 % compared to the last quarter. In essence, while Kwality Pharmaceuticals Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.